Lyso-Globotriaosylceramide (d18:1)
Suppliers
Names
[ CAS No. ]:
126550-86-5
[ Name ]:
Lyso-Globotriaosylceramide (d18:1)
[Synonym ]:
(2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-glucopyranoside
Chemical & Physical Properties
[ Density]:
1.37g/cm3
[ Boiling Point ]:
1005.8ºC at 760 mmHg
[ Molecular Formula ]:
C36H67NO17
[ Molecular Weight ]:
785.91400
[ Flash Point ]:
562.1ºC
[ Exact Mass ]:
785.44100
[ PSA ]:
303.93000
[ Vapour Pressure ]:
0mmHg at 25°C
[ Index of Refraction ]:
1.591
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ RIDADR ]:
NONH for all modes of transport
Articles
Clin. Chim. Acta 414 , 273-80, (2012)
Background Fabry disease is a complex, multisystemic and clinically heterogeneous disease, with elevated excretion of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) accumulating i...
Curr. Med. Chem. 20(2) , 280-8, (2013)
Fabry disease is an X-linked, multisystemic lysosomal storage disorder due to alpha-galactosidase A deficiency. It is characterized by the accumulation of glycosphingolipids, mainly globotriaosylceram...
Cancer Res. 66(14) , 7230-6, (2006)
Efficient methods for tumor targeting are eagerly awaited and must satisfy several challenges: molecular specificity, transport through physiologic barriers, and capacity to withstand extracellular or...